Emilio Alba

Emilio Alba

UNVERIFIED PROFILE

Are you Emilio Alba?   Register this Author

Register author
Emilio Alba

Emilio Alba

Publications by authors named "Emilio Alba"

Are you Emilio Alba?   Register this Author

100Publications

2567Reads

21Profile Views

Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its approval.

Oncotarget 2019 Jul 2;10(42):4321-4332. Epub 2019 Jul 2.

Medical Oncology Service, Hospital del Mar, IMIM, Universitat Pompeu Fabra, The Centre of Networked Biomedical Cancer Research (CIBERONC), and Centro Oncológico Clara Campal-HM Delfos, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.27039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611514PMC
July 2019

Risk Prediction Tools Available for Germline BRCA1/2 Mutations Underperform in Prostate Cancer Patients.

Eur Urol Oncol 2019 Jul 12. Epub 2019 Jul 12.

UGCI Oncología Médica, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga, Spain; CNIO-IBIMA Genitourinary Cancer Research Unit, Institute of Biomedical Research in Malaga, Málaga, Spain; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Center, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.06.019DOI Listing
July 2019

Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer.

Pathol Oncol Res 2018 Oct 9;24(4):871-879. Epub 2017 Sep 9.

Division of Medical Oncology, Hospital Virgen de la Victoria, Malaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12253-017-0301-8DOI Listing
October 2018

Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers.

Exp Mol Pathol 2018 06 31;104(3):161-169. Epub 2018 Mar 31.

Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexmp.2018.03.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993858PMC
June 2018

Hereditary breast and ovarian cancer in Andalusian families: a genetic population study.

BMC Cancer 2018 Jun 8;18(1):647. Epub 2018 Jun 8.

Clinical Oncology Unit Hospitales Universitarios Regional y Virgen de la Victoria. Instituto de Investigación Biomédica de Málaga (IBIMA), Campus Teatinos s/n. 29010, Malaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4537-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994127PMC
June 2018

Supervised discretization can discover risk groups in cancer survival analysis.

Comput Methods Programs Biomed 2016 Nov 17;136:11-9. Epub 2016 Aug 17.

Computer Science Department, University of Málaga, Campus de Teatinos S/N, 29071 Málaga, Spain; Málaga Biomedical Research Institute (IBIMA), Málaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmpb.2016.08.006DOI Listing
November 2016

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

N Engl J Med 2016 11 7;375(18):1738-1748. Epub 2016 Oct 7.

From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1609709DOI Listing
November 2016

The ESMO/ASCO Global Curriculum and the evolution of medical oncology training in Europe.

ESMO Open 2016 18;1(1):e000004. Epub 2016 Jan 18.

Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna) and Applied Cancer Research-Institution for Translational Research Vienna (ACR-ITR VIEnna) Centre for Oncology and Haematology Kaiser Franz Josef-Spital , Vienna , Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2015-000004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070208PMC
January 2016

Role of vascular endothelial growth factor C in classical Hodgkin lymphoma.

Leuk Lymphoma 2015 May 7;56(5):1286-94. Epub 2015 Feb 7.

Departamento de Oncohematología, Agencia Sanitaria Costa del Sol, Instituto de Investigación Biomédica de Málaga , Marbella , Spain.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2014.95
Publisher Site
http://dx.doi.org/10.3109/10428194.2014.952227DOI Listing
May 2015

Defining breast cancer intrinsic subtypes by quantitative receptor expression.

Oncologist 2015 May 23;20(5):474-82. Epub 2015 Apr 23.

Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0372DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425383PMC
May 2015

Time to diagnosis of ewing tumors in children and adolescents is not associated with metastasis or survival.

J Clin Oncol 2014 Dec 10;32(35):4020. Epub 2014 Nov 10.

University Hospital Regional and Virgen de la Victoria of Malaga, Malaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.4466DOI Listing
December 2014

A microRNA signature associated with early recurrence in breast cancer.

PLoS One 2014 14;9(3):e91884. Epub 2014 Mar 14.

Laboratorio de Oncología Molecular, Servicio de Oncología Médica, Instituto de Biomedicina de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Málaga, Spain; Departmento de Biología Molecular y Bioquímica, Universidad de Málaga, Málaga, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0091884PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954835PMC
November 2014

Adjuvant high-dose interferon therapy for melanoma: nothing has really changed.

Melanoma Res 2014 Oct;24(5):522-3

Department of Medical Oncology, Hospital Clínico Universitario Virgen de la Victoria, Malaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000101DOI Listing
October 2014

Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses.

Pharmacogenet Genomics 2014 May;24(5):231-7

aSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA bHuman Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Center cSan Carlos University Hospital dInstitute for Health Research, University Hospital Gregorio Marañón, Madrid eUniversity Hospital Virgen de la Victoria, Malaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076106PMC
May 2014

The seed and soil hypothesis revisited: current state of knowledge of inherited genes on prognosis in breast cancer.

Cancer Treat Rev 2014 Mar 16;40(2):293-9. Epub 2013 Sep 16.

Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Campus Teatinos s/n, 29010 Málaga, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2013.09.010DOI Listing
March 2014

18F-FDG-PET/CT in predicting pathologic complete response after neoadjuvant chemotherapy: the early metabolic response is the answer.

Eur J Cancer 2013 Nov 16;49(16):3573-4. Epub 2013 Sep 16.

Department of Nuclear Medicine, University Hospital Virgen de la Victoria, Málaga, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.07.151DOI Listing
November 2013

Bevacizumab in advanced breast cancer: a new model for the assessment of activity in non-first-line treatment regimens.

Anticancer Drugs 2013 Oct;24(9):975-9

Medical Oncology Department, Institute of Biomedical Research of Córdoba, Reina Sofía University Hospital, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e328363ccbbDOI Listing
October 2013

SEOM recommendations on the structure and operation of hereditary cancer genetic counseling units (HCGCUs).

Clin Transl Oncol 2013 Jan 22;15(1):20-5. Epub 2012 Aug 22.

Complejo Asistencial Universitario de Burgos, Burgos, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12094-012-0920-1DOI Listing
January 2013

Serum protein levels following surgery in breast cancer patients: a protein microarray approach.

Int J Oncol 2012 Dec 16;41(6):2200-6. Epub 2012 Oct 16.

Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Campus de Teatinos s/n, 29010 Malaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2012.1667DOI Listing
December 2012

Practical guidelines for dose individualization of anticancer targeted drugs.

Clin Transl Oncol 2012 Nov 12;14(11):812-9. Epub 2012 Oct 12.

Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Campus Universitario Teatinos s/n, 29010, Málaga, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s12094-012-0932
Web Search
http://link.springer.com/10.1007/s12094-012-0932-x
Publisher Site
http://dx.doi.org/10.1007/s12094-012-0932-xDOI Listing
November 2012

Targeted therapies in the treatment of germ cell tumors: the need for new approaches against "orphan" tumors.

Crit Rev Oncol Hematol 2012 Sep 9;83(3):444-51. Epub 2012 Jan 9.

Medical Oncology Service, Hospital Universitario Virgen de la Victoria of Málaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2011.12.001DOI Listing
September 2012

Functions and workload of medical oncologists in Spain.

Clin Transl Oncol 2012 Jun;14(6):423-9

Servicio de Oncología Médica, Hospital Universitario 12 de Octubre, Avda. de Córdoba, s/n - km 5,400, ES-28041 Madrid, Spain.

View Article

Download full-text PDF

Source
June 2012

Tyrosine kinase inhibitors and drug interactions: a review with practical recommendations.

Clin Transl Oncol 2012 Feb;14(2):94-101

Servicio de Oncología Médica, Hospital Clínico Virgen de la Victoria, Málaga, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12094-012-0767-5
Publisher Site
http://dx.doi.org/10.1007/s12094-012-0767-5DOI Listing
February 2012

SEOM clinical guidelines: a necessary tool.

Authors:
Emilio Alba

Clin Transl Oncol 2011 Aug;13(8):519

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12094-011-0690-1DOI Listing
August 2011

Update on the diagnosis of cancer of unknown primary (CUP) origin.

Clin Transl Oncol 2011 Jul;13(7):434-41

Department of Pathology, Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona, Badalona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12094-011-0679-9DOI Listing
July 2011

Outcome of small invasive breast cancer with no axillary lymph node involvement.

Breast J 2011 Jan-Feb;17(1):32-8. Epub 2010 Dec 6.

Service of Medical Oncology, Virgen de la Victoria University Hospital, Málaga, Spain Service of Medical Oncology, Serranía de Ronda Hospital, Málaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4741.2010.01026.xDOI Listing
May 2011

Multimodal treatment of desmoid tumours: the significance of local control.

Clin Transl Oncol 2011 Mar;13(3):189-93

Department of Clinical Oncology, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12094-011-0639-4DOI Listing
March 2011

Regional and seasonal influence in patient's toxicity to adjuvant chemotherapy for early breast cancer.

Breast Cancer Res Treat 2011 Jan 28;125(1):273-8. Epub 2010 Aug 28.

Servicio de Oncología Médica, Hospital Universitario Reina Sofía, Avda Menendez Pidal s/n, 14005 Córdoba, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10549-010-1136
Web Search
http://link.springer.com/10.1007/s10549-010-1136-0
Publisher Site
http://dx.doi.org/10.1007/s10549-010-1136-0DOI Listing
January 2011

Missing data imputation using statistical and machine learning methods in a real breast cancer problem.

Artif Intell Med 2010 Oct 16;50(2):105-15. Epub 2010 Jul 16.

Departamento de Lenguajes y Ciencias de la Computación, Universidad de Málaga, E.T.S.I. Informática, Campus de Teatinos s/n, 29071 Málaga, Spain.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09333657100006
Publisher Site
http://dx.doi.org/10.1016/j.artmed.2010.05.002DOI Listing
October 2010

Optimal adjuvant hormonal therapy in postmenopausal women with hormone-receptor-positive early breast cancer: have we answered the question?

Clin Transl Oncol 2010 Sep;12(9):614-20

Medical Oncology Department, Hospital Universitario Virgen de Victoria, Málaga, Spain.

View Article

Download full-text PDF

Source
September 2010

Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer.

BMC Cancer 2010 Apr 13;10:136. Epub 2010 Apr 13.

Servicio de Oncología Médica, Hospital Universitario Virgen de Victoria, Campus de Teatinos s/n, 29010 Málaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-10-136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868051PMC
April 2010

Maintenance treatment in metastatic breast cancer.

Expert Rev Anticancer Ther 2008 Dec;8(12):1907-12

Medical Oncology Service, Hospital Universitario Virgen de Victoria, Málaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.8.12.1907DOI Listing
December 2008

Diagnosis and medical treatment of breast cancer. Cordoba Consensus of 2007.

Clin Transl Oncol 2008 Sep;10(9):552-9

Medical Oncology Department, Hospital Universitario Reina Sofía, Córdoba, Spain.

View Article

Download full-text PDF

Source
September 2008

Combined oral cyclophosphamide and bevacizumab in heavily pre-treated ovarian cancer.

Clin Transl Oncol 2008 Sep;10(9):583-6

Medical Oncology Service, Hospital Universitario Virgen de la Victoria, Málaga, Spain.

View Article

Download full-text PDF

Source
September 2008

The functional interaction of 14-3-3 proteins with the ERK1/2 scaffold KSR1 occurs in an isoform-specific manner.

J Biol Chem 2008 Jun 21;283(25):17450-62. Epub 2008 Apr 21.

Departamento de Biología Molecular y Bioquímica, Universidad de Málaga, 29071 Málaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M709185200DOI Listing
June 2008

Playing only one instrument may be not enough: limitations and future of the antiangiogenic treatment of cancer.

Bioessays 2007 Nov;29(11):1159-68

Department of Molecular Biology and Biochemistry, Faculty of Science, University of Málaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bies.20655DOI Listing
November 2007

Presentation of Hodgkin's lymphoma with Ophelia syndrome.

J Clin Oncol 2007 May;25(13):1802-3

Oncology Department, Hospital Clinico Universitario, Malaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.10.0578DOI Listing
May 2007

Treatment for relapse in stage I/II Hodgkin's lymphoma after initial single-modality treatment.

Clin Lymphoma Myeloma 2006 Mar;6(5):389-92

Oncology Department, Hospital Clinico Universitario, Malaga, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2006.n.015DOI Listing
March 2006

Elevated serum levels of vascular endothelial growth factor are associated with tumor-associated macrophages in primary breast cancer.

Am J Clin Pathol 2006 Jan;125(1):111-8

Department of Pathology, Virgen de la Victoria University Hospital, Málaga, Spain.

View Article

Download full-text PDF

Source
January 2006

Looking for the right drug for the right patient: a tale of old drugs and new pathways.

Clin Transl Oncol 2005 Oct;7(9):375-6

View Article

Download full-text PDF

Source
October 2005

[Epidemiological study of the GEICAM group about breast cancer in Spain (1990-1993): El Alamo project].

Med Clin (Barc) 2004 Jan;122(1):12-7

Servicio de Oncología Médica, Hospital Universitario San Carlos, Madrid, Spain.

View Article

Download full-text PDF

Source
January 2004